Skip to main content
. 2016 Nov 21;2016:3850402. doi: 10.1155/2016/3850402

Figure 3.

Figure 3

Effect of allicin treatment on (a) vascular reactivity to angiotensin II, (b) changes (Δ) of coronary perfusion pressure, and (c) angiotensin II type 1 receptor (AT1R) expression in heart. CT: control; CKD: chronic kidney disease; CKDA: chronic kidney disease treated with allicin. Values represent mean ± SD of at least 6 animals from each experimental group. p < 0.05 versus CT and # p < 0.05 versus CKD.